[ad_1]
Citigroup equity strategist Scott Chronert has a list of reasons why a pullback this summer could be triggered in the stock market
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...